SELLAS Life Sciences Group, Inc.
NASDAQSLS short availability crashes to 7%, hitting near-52-week lows as utilization stays pinned at 94.58%—highest borrow demand of the year signals bears are locked in despite 72% monthly gains.
Snapshot as of 21 May 2026
SELLAS Life Sciences Group has gained 45% in a week, yet short sellers have barely moved — and the borrow market is tightening again. A week ago this note flagged the tension between a rallying biotech and an…
SELLAS Life Sciences Group just beat Q1 estimates and is weeks from a pivotal trial readout — and more than 30% of its free float is still held short. That tension is the whole story this week. SLS reported Q1 EPS of…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SLS — free to start on ORTEX.
Sign up for free →Open SLS on ORTEX